Bodal Chemicals Balance Sheet Health
Financial Health criteria checks 3/6
Bodal Chemicals has a total shareholder equity of ₹10.7B and total debt of ₹8.2B, which brings its debt-to-equity ratio to 76.2%. Its total assets and total liabilities are ₹21.8B and ₹11.1B respectively. Bodal Chemicals's EBIT is ₹431.2M making its interest coverage ratio 1.1. It has cash and short-term investments of ₹81.5M.
Key information
76.2%
Debt to equity ratio
₹8.18b
Debt
| Interest coverage ratio | 1.1x |
| Cash | ₹81.46m |
| Equity | ₹10.73b |
| Total liabilities | ₹11.05b |
| Total assets | ₹21.78b |
Recent financial health updates
Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jul 23
Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jan 13Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Jul 18These 4 Measures Indicate That Bodal Chemicals (NSE:BODALCHEM) Is Using Debt Extensively
Mar 06Here's Why Bodal Chemicals (NSE:BODALCHEM) Has A Meaningful Debt Burden
Nov 22Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Aug 10
Recent updates
When Should You Buy Bodal Chemicals Limited (NSE:BODALCHEM)?
Apr 04Need To Know: This Analyst Just Made A Substantial Cut To Their Bodal Chemicals Limited (NSE:BODALCHEM) Estimates
Aug 18Increases to Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Might Cool off for now
Sep 20Bodal Chemicals' (NSE:BODALCHEM) Dividend Will Be ₹0.80
Sep 04Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jul 23Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jan 13Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Jul 18Should You Investigate Bodal Chemicals Limited (NSE:BODALCHEM) At ₹95.80?
Apr 08Bodal Chemicals Limited's (NSE:BODALCHEM) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Mar 21These 4 Measures Indicate That Bodal Chemicals (NSE:BODALCHEM) Is Using Debt Extensively
Mar 06How Is Bodal Chemicals' (NSE:BODALCHEM) CEO Compensated?
Feb 19Is Bodal Chemicals Limited (NSE:BODALCHEM) A Great Dividend Stock?
Feb 06What Percentage Of Bodal Chemicals Limited (NSE:BODALCHEM) Shares Do Insiders Own?
Jan 22Would Shareholders Who Purchased Bodal Chemicals' (NSE:BODALCHEM) Stock Three Years Be Happy With The Share price Today?
Jan 06Are Insiders Buying Bodal Chemicals Limited (NSE:BODALCHEM) Stock?
Dec 22Bodal Chemicals Limited (NSE:BODALCHEM) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Dec 07Here's Why Bodal Chemicals (NSE:BODALCHEM) Has A Meaningful Debt Burden
Nov 22Is Bodal Chemicals Limited (NSE:BODALCHEM) A Strong Dividend Stock?
Nov 07Is Bodal Chemicals (NSE:BODALCHEM) Likely To Turn Things Around?
Oct 13What You Need To Know About Bodal Chemicals Limited's (NSE:BODALCHEM) Investor Composition
Sep 25Who Has Been Buying Bodal Chemicals Limited (NSE:BODALCHEM) Shares?
Sep 09If You Had Bought Bodal Chemicals (NSE:BODALCHEM) Stock Five Years Ago, You Could Pocket A 144% Gain Today
Aug 25Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Aug 10What Did Bodal Chemicals' (NSE:BODALCHEM) CEO Take Home Last Year?
Aug 10Should Bodal Chemicals Limited (NSE:BODALCHEM) Be Part Of Your Income Portfolio?
Jul 29Bodal Chemicals Limited's (NSE:BODALCHEM) Shares May Have Run Too Fast Too Soon
Jul 14The Trends At Bodal Chemicals (NSE:BODALCHEM) That You Should Know About
Jul 12Bodal Chemicals Limited's (NSE:BODALCHEM) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Jun 27Financial Position Analysis
Short Term Liabilities: BODALCHEM's short term assets (₹8.0B) exceed its short term liabilities (₹6.1B).
Long Term Liabilities: BODALCHEM's short term assets (₹8.0B) exceed its long term liabilities (₹5.0B).
Debt to Equity History and Analysis
Debt Level: BODALCHEM's net debt to equity ratio (75.5%) is considered high.
Reducing Debt: BODALCHEM's debt to equity ratio has increased from 21.8% to 76.2% over the past 5 years.
Debt Coverage: BODALCHEM's debt is well covered by operating cash flow (25.2%).
Interest Coverage: BODALCHEM's interest payments on its debt are not well covered by EBIT (1.1x coverage).